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Mycoplasma bovis is a highly contagious agent associated with several pathologies in cattle. The 
detection of reactive antibodies to M. bovis by Indirect Enzyme-Linked Immunosorbent Assay (iELISA) 
identifies if there was an exposure to the microorganism. The current study aimed to optimize an iELISA 
from M. bovis total cell antigen, applying it to bovine serum samples, and to evaluate risk factors. Serum 
samples were obtained from 400 cows from 17 herds from Southeast Brazil. In the optimization of 
iELISA, the following was established: 2 μg/mL of antigen, sera dilution 1:300, and conjugate dilution 
1:15000. The frequency was 62.3% (249/400) of reactive animals and 100% (17/17) of reactive herds. 
Risk factors were: herds with more than 100 animals (OR= 3.1; CI= 95%); Holstein breed (OR= 72.5;  
CI= 95%); cows (OR= 29.7;  CI= 95%); intensive breeding system (OR= 3.3; CI= 95%); associated small 
ruminant production (OR= 4.4; CI= 95%); milk production above 500L (OR= 2.9; CI= 95%); no 
quarantine (OR= 1.5; CI= 95%); mechanical milking (OR= 5.5; CI= 95%) and cases of mastitis (OR= 
5.5; CI= 95%). The proposed iELISA was able to detect antibodies reactive to M. bovis in bovine serum. 
Knowledge of these risk factors can assist in the implementation of prophylactic measures.  
 




Mycoplasma bovis é um agente altamente contagioso relacionado a várias patologias em bovinos. A 
detecção de anticorpos reativos a M. bovis por Ensaio de Imunoadsorção Enzimática Indireto (iELISA) 
identifica se houve exposição ao microrganismo. O presente estudo teve como objetivo otimizar um 
iELISA de antígeno celular total de M. bovis, aplicando-o a amostras de soro bovino, bem como avaliar 
fatores de risco. Amostras de soro foram obtidas de 400 vacas de 17 rebanhos da Região Sudeste do 
Brasil. Na otimização do iELISA foram obtidos: 2μg/mL de antígeno, diluição dos soros 1:300 e do 
conjugado 1:15000. A frequência de animais reativos foi de 62,3% (249/400) e de 100% (17/17) para os 
rebanhos. Os fatores de risco foram: rebanhos com mais de 100 animais (OR= 3,1; IC= 95%); raça 
Holandesa (OR= 72,5;IC= 95%); vacas (OR= 29,7;IC= 95%); sistema intensivo (OR= 3,3; C= 95%); 
produção de pequenos ruminantes (OR= 4,4;IC=95%); produção de leite acima de 500L (OR= 2,9;IC= 
95%); sem quarentena (OR= 1,5;IC= 95%); ordenha mecânica (OR= 5,5;IC= 95%) e casos de mastite 
(OR= 5,5;IC= 95%). O iELISA proposto foi capaz de detectar anticorpos reativos a M. bovis no soro 
bovino. O conhecimento desses fatores de risco pode auxiliar na implementação de medidas profiláticas. 
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INTRODUCTION 
 
Mycoplasma species can cause a variety of 
diseases in cattle, such as mastitis, otitis media, 
conjunctivitis, endocarditis, respiratory, joint, 
brain and reproductive disorders. Mycoplasma 
bovis is highly contagious and the leading agent 
involved in cases of mastitis in dairy cattle. It can 
cause outbreaks in the clinical form with a 
decrease in milk production and quality, leading 
to the early culling of animals, while in the 
subclinical form, it is responsible for the 
maintenance and dissemination of the agent in 
the herd (Maunsell et al., 2011; Fox, 2012; 
Arede et al., 2016; Rosales et al., 2017; Kanda et 
al., 2019).  
 
Mycoplasma bovis is commonly associated with 
chronic diseases in cattle. Once established in the 
herd, it is difficult to eradicate, due both to its 
invasion of epithelial and immune cells and 
dissemination to inaccessible parts of the 
organism, making treatment with antibiotics 
difficult. Additionally, only a few groups of 
antimicrobials can be used in its treatment, due 
to the absence of a cell wall. Furthermore, its 
widespread use has resulted in observed 
resistance to these drugs. Moreover, M. bovis has 
great antigenic variation, which hinders the 
development of vaccines for its control (Pretto et 
al., 2001; Burki et al., 2015; Perez-Casal et al., 
2017).  
 
Acquisition of new, asymptomatic animals, a 
lack of prior knowledge of their clinical history, 
increased herd size, as well as agglomeration and 
confinement are associated with a greater risk of 
infection by M. bovis, which may contribute to 
the morbidity and mortality of animals (Maunsell 
et al., 2011; Fox, 2012; Aebi et al., 2015; 
Lysnyansky et al., 2016; Wawegama et al., 
2016). Antibody expression against M. bovis 
may persist for several months. Diagnosis by 
Indirect Enzyme-Linked Immunosorbent Assay 
(iELISA) detects antibody response, bypassing 
the need for the active shedding of 
microorganisms at sample collection. Thus, 
iELISA is an essential tool for verifying the 
maintenance of M. bovis-free herds, as well as 
the introduction of newly acquired animals in the 
herd (Parker et al., 2018). According to previous 
research in Portugal, Brazil, China and Australia, 
the between-herd prevalence of M. bovis by 
iELISA has been found to vary between 46.7% 
and 98.0% (Raposo, 2009; Mesquita et al., 2015) 
and within-herd between 3.1% and 98.0% 
(Raposo, 2009; Fu et al., 2014; Mesquita et al., 
2015; Hazelton et al., 2018).  
 
Commercial iELISA kits such as Bio K 260 and 
Bio K 302 (Bio-X Diagnostics- Rochefort, 
Belgium) and Bovicheck M. bovis (Biovet Inc- 
Quebec, Canada) are available for the detection 
of anti- M. bovis antibodies in serum, plasma, 
and bovine milk samples (Parker et al., 2018). 
However, these kits are not yet available in some 
countries, such as Brazil. Additionally, there is a 
report on the development of an in-house 
iELISA for the detection of anti- M. bovis 
antibodies that shows better results when 
compared to kits (Wawegama et al., 2014, 2016). 
The current study aimed to optimize an iELISA 
from M. bovis total cell antigen, applying it to 
bovine serum samples, and to evaluate risk 
factors.  
 
MATERIALS AND METHODS 
 
This study was approved by the Ethics 
Committee on the Use of Animals (CEUA) of 
Universidade Federal Fluminense (UFF), under 
certificate number 987/2017. Mycoplasma bovis 
Donetta PG 45 from the Mollicutes collection 
from Universidade de São Paulo (USP) was 
cultivated in modified Frey medium (Frey et al., 
1968). Confirmation of growth was checked by 
the color change in the liquid medium and 
visualization of typical colonies in the shape of a 
“fried egg” in a solid medium with a 
stereomicroscope (Biofocus®, Brazil). The strain 
was cultivated in increasing volumes up to 1L, at 
10% of the culture medium volume. For each 
batch, a plate was prepared to verify the log 
growth phase of the strain (“massal” growth). 
The culture in liquid medium was centrifuged at 
4ºC, at 3136 x g for 40 minutes (Hettich 
Zentrifugen, 420R®, Germany), and the 
supernatant discarded. The pellet was 
resuspended in phosphate-buffered saline (PBS) 
solution pH 7.2 and centrifuged once again as 
before. The procedure was repeated twice, and 
the final pellet re-suspended in 2 mL of PBS and 
kept at -20oC until protein dosage. The protein 
concentration was determined (Lowry et al., 
1951) to detect the concentration of antigen for 
the sensitization of microtiter plates.   
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To determine the ideal M. bovis antigen 
concentration, 2, 4 and 8 µg/mL of antigen were 
tested in the sensitization of microtiter plates 
(Kartell®, Italy), with the dilution performed in 
0.1M carbonate-bicarbonate buffer, pH 9.6. In 
order to determine the optimal serum dilution, a 
commercial sterile fetal bovine serum (Sigma 
Chemical Co. St Louis, MO®, United States) as 
a negative control and M. bovis hyper-immune 
reactive bovine serum as a positive control were 
used (Mesquita et al., 2015). The tests were 
performed with the controls distributed in a base 
2 serial dilution (ranging from 1/100 to 1/3200) 
and a base 3 serial dilution (ranging from 1/100 
to 1/24300). For the determination of the optimal 
dilution of the conjugate, rabbit anti-bovine IgG 
conjugated with peroxidase enzyme (Sigma 
Chemical Co. St Louis, MO®, United States) 
was used, and dilutions of 1:10000 and 1:15000 
were tested. The chromogenic substrate used was 
ortho-phenylenediamine (OPD) (Sigma 
Chemical Co. St Louis, MO®, United States), 
and the reaction was stopped with 3N sulfuric 
acid. Reading of optical densities (O.D) was 
performed with an ELISA reader (DNM-9602, 
Beijing Perlong New Technologies Ltd.®, 
China) at a 450 nm wavelength.  
  
Sampling was based on an estimated prevalence 
of 50% (since M. bovis antibody frequency is 
unknown in the studied region), with a 95% 
confidence interval and a 5% error, according to 
the formula n= Z² x P (1-P) / E² (Thrusfield, 
2004), requiring at least 384 animals. In this 
way, 400 cows were selected from 17 bovine 
herds from dairy basins in Southeast Brazil as 
follows: Minas Gerais state (n=147), 
municipalities of Juiz de Fora (n=68) and 
Belmiro Braga (n=79); Rio de Janeiro state 
(n=151), municipalities of Cachoeiras de Macacu 
(n=44), Duas Barras (n=25), Rio Bonito (n=14), 
Teresópolis (n=26) and Valença (n=42); and São 
Paulo state (n=102), municipalities of Areias 
(n=30), Silveiras (n=33) and São José do 
Barreiro (n=39). Herds were selected by 
convenience (non-probabilistic sampling) and 
animals from each herd were randomly selected. 
 
Based on a cross-sectional study, between March 
2018 and July 2019, blood samples were 
collected from apparently healthy females of 
reproductive age, from different ages, breeds and 
stages of lactation, with unknown previous 
clinical history. Before collection, antisepsis was 
performed with 70% ethyl alcohol, and then the 
caudal vein was punctured with a sterile needle 
and Vacutainer® adapter and packed in a tube 
without anticoagulant. Meanwhile, a 
questionnaire to investigate milking management 
was applied to those responsible for herds for 
risk factor analysis. Samples were transported 
under refrigeration, not exceeding four hours 
from collection, then under laboratory conditions 
tubes were centrifuged at 591 x g (HT®, Brazil) 
for 15 minutes to obtain serum, which was 
transferred to microtubes and stored at -20oC 
until iELISA performance. 
 
Samples were tested in triplicate, according to 
the ideal conditions obtained during the 
optimization step, with detection of O.D 
performed as previously described. The 
reactivity of each sample was calculated by 
determining the sample/positive serum ratio 
(S/P), using positive and negative control sera as 
a reference, where S/P= (sample mean - negative 
control mean) / (positive control mean - negative 
control mean). The cutoff value was determined 
to be two and a half times the mean absorbance 
of the negative control, and readings above the 
cutoff were considered reactive (Baldani et al., 
2004). 
 
For iELISA optimization, Analysis of Variance 
(ANOVA) was performed with a 95% 
significance level to determine the ideal 
concentration of antigen, serum dilution and 
conjugate dilution. The relative frequency of 
bovine serum samples reactive to iELISA by 
state was performed using Pearson's chi-square 
test with a 95% significance level. For prior 
analysis of risk factors was performed Pearson's 
chi-square test or Fisher's exact test with a 90% 
significance level to prevent possible risk factors 
from being excluded from the analysis (Murai 
and Higuchi, 2019). Logistic regression analysis 
was then performed, with a 95% significance 
level. The iELISA result was considered a 
dependent variable, while the independent 
variables were: herd size (up to 100; more than 
100), predominant breed (Holstein; crossbred), 
age (cows; heifers), rearing system (intensive; 
semi-intensive; extensive), small ruminant 
breeding (yes; no), average herd milk production 
(up to 500L; more than 500L), quarantine in the 
acquisition of new animals (yes; no), type of 
milking (mechanical; manual), California 
Mastitis Test (CMT) application (yes; no) and 
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occurrence of mastitis in the herd (yes, no). All 
analyses were performed using BioEstat 5.0 




Protein dosage of M. bovis antigen was 1.8 
mg/mL, validated by an R2 value of 0.9956. In 
order to determine the ideal antigen 
concentration, the most economical conditions 
were chosen as follows: base 3 serial dilution of 
sera and dilution of the conjugate 1:15000, with 
concentrations of 2, 4, and 8 μg/mL of antigen 
for sensitizing the plates. There was no 
difference (p>0.05) for the positive control (p= 
0.9536) and the negative control (p=0.5790) in 
the tested concentrations. The increase in antigen 
concentration did not imply an increase in the 
O.D of the positive control. Therefore, a 
concentration of 2 μg/mL of antigen was chosen 
to sensitize the microtiter plates, as it was the 
most economical (Figure 1a).  
In the serum dilution test, the plates were 
sensitized with 2 μg/mL of antigen and dilution 
of the conjugate 1:15000. There were lower 
baseline values for the negative controls, as well 
as better discrimination between the positive and 
negative controls in the base 3 serial dilution, 
with the greatest discrimination in the 1:300 
dilution (positive control value 8.3 times greater 
than that of the negative) (Figure 1b). In order to 
test the conjugate dilutions (1:10000 and 
1:15000), the plates were sensitized with 2 
μg/mL of antigen and the base 3-diluted sera. 
There was no difference (p>0.05) between the 
two conjugate dilutions for the positive 
(p=0.1119) and negative (p=0.0824) controls. It 
was possible to verify good discrimination 
between the positive and negative controls in 
both dilutions, although dilution 1:15000 was 




Figure 1. Optimization of iELISA. (a) Determination of the ideal concentration of Mycoplasma bovis total 
cell antigen testing 2, 4 and 8 µg/mL in the sensitization of microtiter plates (p<0.05), with base 3 dilution 
of sera and dilution of the conjugate 1:15000. (b) Determination of the ideal serum dilution with positive 
(M. bovis hyper-immune reactive bovine serum) and negative (commercial sterile fetal bovine serum) 
serum control using base 2 and base 3 serial dilution (p<0.05), with a concentration of M. bovis antigen of 
2 µg/mL and dilution of conjugate at 1:15000. (c) Determination of the ideal conjugate dilution (rabbit 
anti-bovine IgG conjugated with the enzyme peroxidase) at 1:10000 and 1:15000 (p<0.05), with a 
concentration of M. bovis antigen of 2 µg/mL and base 3 dilution of the sera.  
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The total frequency of reactive serum animals 
was 62.3% (249/400), and in 100% (17/17) of 
the herds there were reactive animals. 
Concerning the states, there were reactive 
animals in all municipalities studied (shown in 
Figure 2), and a greater seropositivity (p<0.0001) 
in São Paulo state (98.1%; 100/102) when 
compared to Minas Gerais (60.5%; 89/147) and 




Figure 2. Frequency of bovine serum samples reactive to iELISA Mycoplasma bovis total cell antigen 
from dairy cattle from municipalities of the states of São Paulo, Minas Gerais and Rio de Janeiro, 
Southeast Brazil, from March 2018 to July 2019.  
 
Risk factors were: herds with more than 100 
animals (OR= 3.1, CI= 95%), Holstein breed 
(OR= 72.5, CI= 95%), age of cows (OR= 29.7, 
CI= 95%), intensive breeding system (OR=3.3, 
CI= 95%),  small ruminant breeding (OR= 4.4, 
CI= 95%), milk production greater than 500L 
(OR= 2.9, CI= 95%), no quarantine (OR= 1.5, 
CI= 95%), mechanical milking (OR=5.5, CI= 
95%) and cases of mastitis in the herd (OR=5.5, 




In the current study the ideal antigen 
concentration for sensitizing microtiter plates 
was the same found by Mesquita et al. (2015), 
who did not evaluate the dilutions of serum and 
conjugate, but instead kept the base 2 dilution of 
serum and conjugate at 1:10000. The frequency 
of reactive animals (62.3%) and herds (100%) 
here was higher than observed in the later study 
(3.1% and 46.7%, respectively), which may have 
been due to the difference in the studied regions. 
It is also likely that the optimization of sera and 
conjugate dilution conditions in this study 
produced an iELISA more sensitive in its 
detection of reactive serum to the total antigen of 
M. bovis.  
 
Our results were compatible with the detection of 
M. bovis worldwide. In Europe, Raposo (2009) 
detected serum reactivity of 98.0% for both herds 
and animals in Portugal and Fodor et al. (2017) 
reported a frequency of 82.9% for animals and 
100% for herds in Hungary. Fu et al. (2014) 
reported a variation of 43.9% to 75.8% in 
seroreactive animals from China and 93.8% of 
cattle in Australia were also reactive to M. bovis 
(Hazelton et al., 2018), however in both studies 
the animals had clinical manifestations, which 
did not occur in the present study where the 
previous clinical history of each animal was 
unknown.  
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Table 1. Risk factors associated with bovine seroreactivity in iELISA Mycoplasma bovis total cell antigen 
in dairy cattle from municipalities from the states of São Paulo, Minas Gerais and Rio de Janeiro, 
Southeast Brazil, from March 2018 to July 2019 








OR (CI 95 %)1 
p- value 
Herd size 
Up to 100 135 72 (53.3) 
0.0118(A) 3.1 (1.4-6.8) 0.0059(C) More than 
100 
265 177 (66.8) 
Predominant breed 
Holstein 59 53 (89.8) 
0(B) 72.5(6.4-817.1) 0.0005(C) 
Crossbred 341 196 (57.5) 
Age 
Cows 290 204 (70.3) 
< 0.0001(A) 29.7(11.1-79.3) <0.0001(C) 
Heifers 110 45 (40.9) 
Rearing system 
Intensive 50 42 (84.0)  
3.3 (1.6-7.1) 0.0013(D) 
Semi-
intensive 
320 198 (61.9) <0.0001(A) 
Extensive 30 09 (30.0)  
Small ruminant 
breeding 
Yes 74 58 (78.4) 
0.0024(A) 4.4 (1.9-10.6) 0.0008(C) 
No 326 191 (58.6) 
Average herd 
production 
Up to 500L 208 106 (51.0) 
< 0.0001(A) 2.9 (1.4-6.4) 0.0059(C) More than 
500L 
192 143 (74.5) 
Quarantine 
No 257 170 (66.1) 
0.0405(A) 1.5 (1.0-2.4) 0.0316(D) 
Yes 143 79 (55.2) 
Type of milking 
Mechanical 384 243 (63.3) 
0.0618(B) 5.5 (1.6-19.0) 0.0064(C) 
Manual 16 06 (37.5) 
CMT2 
application 
No 289 178 (61.6) 
0.7466(A) - - 
Yes 111 71 (64.0) 
Cases of mastitis in 
the herd 
Yes 336 219 (65.2) 
0.0086(A) 5.5 (1.5-19.3) 0.0086(C) 
No 64 30 (46.9) 
(A) Associations assessed by Pearson's Chi-square (p<0.10); (B) Fisher's Exact test (p<0.10).   
(C)Associations assessed by multiple logistic regression (p<0.05); (D) Associations assessed by simple logistic 
regression (p <0.05). 1Odds ratio (Confidence Interval); 2 California Mastitis Test. 
 
Mycoplasma bovis is primarily an inhabitant of 
respiratory mucosal surfaces, often found in the 
upper respiratory tract of healthy cattle and may 
cause infection in immunosuppressed animals. 
Transmission between different body sites in the 
same animal can occur by lymphatic and blood 
routes, and intramammary and respiratory 
infection induce active humoral responses 
(Maunsell et al., 2011; Fox, 2012). Mycoplasma 
bovis generally causes chronic infection due to 
great antigenic variation, allowing it to escape 
from the host's immune system. The invasion of 
epithelial and immune cells allows its 
dissemination to sites of difficult access in the 
organism, which may cause suppression of the 
host's responses and the formation of biofilm that 
guarantees its permanence in the host (Burki et 
al., 2015; Perez-Casal et al., 2017). Chronic 
infections are more easily detected by iELISA 
than by Polimerase Chain Reaction (PCR) and 
culture, which explains the high infection rates 
detected in serological analysis (Parker et al., 
2018). 
 
Regarding risk factors, infection with M. bovis 
was about three times greater in herds with more 
than 100 animals and in those with an average 
production of more than 500L. Such results 
corroborate Fox (2012), who reports a greater 
infection by M. bovis in larger herds with greater 
production, which occurs due to the greater 
circulation (buying and selling) of often 
asymptomatic carriers of M. bovis (Maunsell et 
al., 2011; Pardon et al., 2020). 
 
Holstein breed was the greatest risk factor, more 
than 70 times greater when compared to 
crossbred cows. It is already known that one of 
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the main factors related to low productivity, 
fertility and health in Holstein cattle, managed 
under tropical conditions, is heat stress and that 
crossbreed animals have shown greater 
environmental adaptability (Khan et al., 2018; 
Gernand et al., 2019). Additionally, purebred 
animals are often kept under intensive breeding 
systems, which was a risk factor when 
individually analyzed by simple logistic 
regression, with a risk of infection about three 
times greater than in animals raised under other 
breeding systems. Similarly, Wawegama et al. 
(2016) detected greater antibody response for M. 
bovis in beef cattle kept under confinement in 
Australia. 
 
Risk in cows was almost 30 times higher when 
compared to heifers, corroborating Aebi et al. 
(2015), who found that the number of lactations 
is a risk factor. Also, in herds where cases of 
mastitis were reported there was a risk more than 
five times higher than in herds with no cases of 
clinical or subclinical mastitis. It has been 
suggested that the production of antibodies 
reactive to M. bovis is due to infection of the 
mammary glands with or without a manifestation 
of clinical signs (Parker et al., 2018).  
 
The risk of infection when performing 
mechanical milking was 5.5 times greater than 
when performing manual milking. Mastitis 
caused by Mycoplasma spp. is contagious, in 
which the pathogen infects the udder, and is 
transmitted horizontally during milking through 
fomites and milkers' hands (Fox, 2012). In this 
case, the greatest risk of transmission occurred 
through the use of a mechanical milking 
machine, corroborating Aebi et al. (2015), who 
found a greater risk of infection with a specific 
brand of milking equipment. Therefore, authors 
reiterate the importance of hygiene measures 
such as hot water, alkaline and acid detergent in 
utensils and equipment used in mechanized 
milking, as well as respecting the milking line 
order (heifers, younger and older cows without 
mastitis history and cows with mastitis history) 
avoiding cross-infection among animals. 
 
When analyzed by multiple logistic regression, 
lack of quarantine was not a risk factor. 
However, when analyzed by simple logistic 
regression, the risk of infection in unquarantined 
animals was 1.5 greater than in herds where 
isolation protocols were adopted before the 
introduction of newly acquired animals. In this 
way, corroborating the work of Murai and 
Higuchi (2019) and Pardon et al. (2020) the lack 
of a quarantine protocol is a risk factor for M. 
bovis infection.  
 
Concerning contact between animals, the 
production of other ruminant species such as 
goats and sheep was also a risk factor for the 
detection of antibodies reactive to M. bovis in 
iELISA. There may be a cross-reaction with M. 
agalactiae, which affects small ruminants, and in 
some cases, can infect cows, showing a 99.8% 
genetic similarity to M. bovis (Nicholas et al., 
2008). As a result, efforts to serologically 
differentiate both species by means of an iELISA 
based on recombinant proteins have been 
unsuccessful (Sun et al., 2014; Cheema et al., 
2016). Due to such serological limitations, 
molecular techniques have been proposed to 
differentiate them with a greater degree of 





The iELISA proposed was able to detect 
antibodies reactive to M. bovis in bovine serum, 
in which the high frequency of reactive animals 
indicates mycoplasma circulation in dairy cattle 
from Southeast Brazil. Knowledge of these risk 
factors can assist in the implementation of 
prophylactic measures aimed at controlling the 
agent in dairy cattle breeding systems. The risk 
factors can be considered in regions and herds 
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